Long-Term Toxicity of Immune Checkpoint Inhibitors—Time to Widen the Lens

This Viewpoint discusses the need to quantify the long-term adverse effects of immune checkpoint inhibitors, particularly immune-related adverse effects, which are not universally dose dependent, limiting the value of conventional adverse event grading systems.